The National Institute of Chemistry is the winner of this year’s best business practice award as part of the Best of the Best project. The institute has earned the accolade with the CCEdit project for developing the use of the improved CRISPR gene editing system.
The CCEdit project, launched in February 2020 and registered by biochemist Roman Jerala, is continuation of the development and demonstration of the breakthrough technology CRISPR for health and other biotechnological purposes. In addition to improving gene editing technology, the team led by Tomaž Bizjak of the institute’s department for synthetic biology and immunology is establishing an international business and development relationship with foreign organisations. By getting connected with global biotechnology centres and pharmaceutical companies, the project improves its chances of being placed in the market, while contributing to the development of the Slovenian bio-tech start-up sector.
The aim of the project is to bridge the lack of key development resources and know-how using resources from foreign biotechnology centres in order to make progress in the commercialisation of biotechnological and medical innovations. This would encourage decision-makers, researchers and other stakeholders to participate more actively in the development of domestic industry.